VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q1 2022 Results - Earnings Call Transcript

Vascular Biogenics Ltd. (VBLT) Q1 2022 Earnings Conference Call May 17, 2022, 08:30 AM ET Company Participants Dan Ferry - LifeSci Advisors, IR Dror Harats - CEO Sam Backenroth - CFO Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Kevin DeGeeter - Oppenheimer RK Ramakanth - H.C. Wainwright Presentation Operator Greetings, and welcome to the VBL Therapeutics First Quarter 2022 Earnings Confernce Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like turn the conference over to your host, Mr. Dan Ferry of LifeSci Advisors. Please go ahead, Dan. Dan Ferry Thank you, Operator. Good morning, everyone, and thank you for joining the VBL Therapeutics first quarter 2022 financial results and corporate update call. Joining me on the call is Professor Dror Harats, Chief Executive Officer;

For further details see:

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q1 2022 Results - Earnings Call Transcript